Sandesh Mahatme

CIK 1511034 · CFO · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$585.1K

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$50.71M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRSP Director $49.80 $0 3 2026-06-09
VOR CFO 0 $14.36 $0 $0 2 2025-12-09
Spyre Therapeutics, Inc. (AGLE) Delisted Director $12.01 $0 7 2022-06-09
SRPT EVP, CFO & CBO 30,851 $15.31 $472.3K -$50.71M 29 2020-07-09
FLXN Director 4,500 $25.05 $112.7K $0 8 2020-06-12

Recent Filings · Page 4 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-07-27 FLXN Grant (A) $0 EDGAR
2017-07-21 SRPT Mixed +1,500 -$1.25M EDGAR
2017-03-21 SRPT Tax (F) −171 -$5.2K EDGAR
2017-03-14 SRPT Grant (A) $0 EDGAR
2016-11-10 SRPT Exer (M) +1,000 $23.9K EDGAR
2016-10-19 SRPT Mixed -$1.09M EDGAR
2016-09-21 SRPT Grant (A) +24,430 $0 EDGAR
2016-09-02 SRPT Tax (F) −1,013 -$26.4K EDGAR
2016-06-22 FLXN Grant (A) $0 EDGAR
2016-06-13 FLXN Grant (A) $0 EDGAR
Showing 3140 of 49
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.